Navigation Links
UAB joins elite brain cancer research group
Date:7/9/2008

BIRMINGHAM, Ala. Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting-edge hospitals and academic centers working to improve treatment and survival for patients with a kind of malignant brain tumor called a glioma.

As part of the nine-member consortium, UAB will serve as the only research site in the Southeast. UAB is one of four consortium members working in conjunction with its own National Cancer Institute-designated comprehensive cancer center and with a Specialized Program of Research Excellence (SPORE) in brain cancer.

"Being named to this project is a huge honor for us, and it shows we've kept pace and excelled in collaborative and translational research objectives," said G. Yancey Gillespie, Ph.D., UAB professor of neurosurgery and principal investigator for the Ivy Genomics-Based Medicine Project.

Gliomas are tumors that arise by transformation of the body's glial cells, which make up 90 percent of the brain and spinal cord and normally work in concert with neurons. The consortium members strive to unravel how genetic differences between gliomas can lead to more effective and even personalized treatments for patients.

The project will categorize tumors using sophisticated molecular profiling and, for the first time, test each brain tumor against a wide spectrum of treatments to match DNA markers with differences in cancer-fighting response.

"Currently, all patients get basically the same treatment without taking into account the genetic profile of their tumor," said Catherine Ivy, founder of the Ivy Foundation and the driving force behind the genomic project.

"The end goal of this research initiative is to identify how tumors with different genetic features respond to a set of treatment regimens and ultimately, it is hoped, provide physicians with the tools they need to offer brain tumor patients the most effective treatment options," Ivy said.

UAB's membership in the Ivy Genomics-Based Medicine Project is focused on the group's first stage, which has an intensive 18-month research timeline. The nine academic laboratories will use that period to screen dozens of anti-cancer drugs in animal models that help predict tumor-fighting response.

Information from those screenings and other genetic profiling will be linked and analyzed through a secure, real-time computer network. The project's second phase will likely involve human testing of anti-cancer drugs.

Gillespie said the genomic approach has the potential to generate several "firsts" in brain cancer research. "We already are working across disciplines: neuro-oncology, neurosurgery, neuroradiology, neuropathology, pharmacology and biomedical engineering," he said. "This research promises to have a significant impact on the way we treat this disease in the future."


'/>"/>

Contact: Troy Goodman
tdgoodman@uab.edu
205-934-8938
University of Alabama at Birmingham
Source:Eurekalert

Related medicine news :

1. Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases
2. Dr. Kenneth L. Byrd Joins SteriFx Inc.
3. Leading Vaccine Expert Joins IAVI
4. Marshall Norris Joins NavigatorMD as Director of Business Development and Sales
5. Dr. Howard Epstein Joins Blue Cross as Medical Director for Commercial Operations and Clinical Design
6. Uroplasty Joins the Russell Microcap Index
7. Marc Andreessen Joins Facebook Board of Directors
8. Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
9. Former Assistant US Surgeon General Woodie Kessel, MD, MPH, Joins Academic Network LLC as Senior Scientific Advisor
10. Karen Haney Joins The Turning Point Group as Partner and Vice President of Client Services - Healthcare
11. Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
(Date:6/23/2016)... PRINCETON, N.J. , June 23, 2016  Guerbet ... of Premier Inc.,s Supplier Horizon Award . ... this year, Guerbet was recognized for its support of ... value creation through clinical excellence, and commitment to lower ... delighted to receive this recognition of our outstanding customer ...
Breaking Medicine Technology: